Viewing Study NCT04652102


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:35 AM
Study NCT ID: NCT04652102
Status: COMPLETED
Last Update Posted: 2024-04-29
First Post: 2020-12-01
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older
Sponsor: CureVac
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CV-NCOV-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators